[(2S)-2-[(2S,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]phosphonic acid | 934384-76-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: [(2S)-2-[(2S,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]phosphonic acid
• CAS: 934384-76-6
• 化学式: C₁₀H₁₆N₃O₈P
• 分子量: 337.226
• InChiKey: TWLLPPNWXLNVCC-PMPOVCSBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -3.5
• 重原子数：
  22
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  186
• 氢给体数：
  6
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  [(2S)-2-[(2S,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]phosphonic acid 在 DOWEX 50WX₂ (Na+ form) 作用下， 以23 mg的产率得到1-(5S)-[6-deoxy-6-phosphono-β-D-ribohexofuranosyl]cytidine
  参考文献：
  名称：

  含嘧啶核苷 β-(R/S)-羟基膦酸酯类似物的合成

  摘要：

  描述了获得核苷 β-羟基膦酸酯类似物的简明途径。使用核苷 β-酮膦酸酯作为关键中间体允许获得嘧啶系列中 β-羟基膦酸酯类似物的 (R) 和 (S) 异构体。这样的衍生物可以被认为是 5

  DOI：

  10.1002/ejoc.201100219
• 作为产物：
  描述：

  N,N-4(ditert-butoxycarbonyl)-1-(2,3:5,6-di-O-isopropylidene-β-D-ribo-(5R)-hexofuranosyl)cytosine 在 三甲基氯硅烷 、 三甲基溴硅烷 、 水 、 对甲苯磺酸 、 三乙胺 、 三苯基膦 、 三氟乙酸 、 偶氮二甲酸二乙酯 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 11.5h， 生成 [(2S)-2-[(2S,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]phosphonic acid
  参考文献：
  名称：

  An Alternative Pathway to Ribonucleoside β-Hydroxyphosphonate Analogues and Related Prodrugs

  摘要：

  Nucleoside beta-(S)-hydroxyphosphonate analogues have recently proven to be interesting bioactive compounds as 5'-nucleotidase inhibitors. These derivatives were obtained in a pyrimidine series through an ex-chiral pool pathway or the stereoselective reduction of beta-ketophosphonate intermediate. Herein, an original synthesis of these compounds using nucleoside epoxide intermediates, containing either a pyrimidine or a purine as nucleobase, was explored and allowed the direct synthesis of the corresponding bis S-acyl-2-thioethyl (SATE) prodrugs.

  DOI：

  10.1021/ol402143y

文献信息

• Synthesis of Pyrimidine-Containing Nucleoside β-(R/S)-Hydroxyphosphonate Analogues
  作者：Maïa Meurillon、Laurent Chaloin、Christian Périgaud、Suzanne Peyrottes

  DOI：10.1002/ejoc.201100219

  日期：2011.7

  β-hydroxyphosphonate analogues is described. The use of a nucleoside β-ketophosphonate as the key intermediate allowed both the (R) and (S) isomers of β-hydroxyphosphonate analogues in the pyrimidine series to be accessed. Such derivatives may be considered as stable mimics of 5

  描述了获得核苷 β-羟基膦酸酯类似物的简明途径。使用核苷 β-酮膦酸酯作为关键中间体允许获得嘧啶系列中 β-羟基膦酸酯类似物的 (R) 和 (S) 异构体。这样的衍生物可以被认为是 5
• An Alternative Pathway to Ribonucleoside β-Hydroxyphosphonate Analogues and Related Prodrugs
  作者：Audrey Hospital、Maïa Meurillon、Suzanne Peyrottes、Christian Périgaud

  DOI：10.1021/ol402143y

  日期：2013.9.20

  Nucleoside beta-(S)-hydroxyphosphonate analogues have recently proven to be interesting bioactive compounds as 5'-nucleotidase inhibitors. These derivatives were obtained in a pyrimidine series through an ex-chiral pool pathway or the stereoselective reduction of beta-ketophosphonate intermediate. Herein, an original synthesis of these compounds using nucleoside epoxide intermediates, containing either a pyrimidine or a purine as nucleobase, was explored and allowed the direct synthesis of the corresponding bis S-acyl-2-thioethyl (SATE) prodrugs.